Matrix Private Capital Group LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Matrix Private Capital Group LLC
CRD #285531
SEC #801-108654
CIK #0001410830, 0001906866
AUM 561.0 M (2026-03-27)
Employees 8 (62% Investors, 0% Brokers)
Fees
Minimum
Phone312-736-9572
Address500 West Madison Street
Chicago, IL 60661
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($M)
70056042028014002010201520212027
In the News
Wed, 29 Jul 2026 Matrix Private Capital Group LLC Makes New $2.49 Million Investment in JPMorgan Chase & Co. $JPM — MarketBeat
Sun, 26 Jul 2026 Matrix Private Capital Group LLC Acquires Shares of 4,393 International Business Machines Corporation $IBM — MarketBeat
Sun, 26 Jul 2026 Matrix Private Capital Group LLC Takes Position in Taiwan Semiconductor Manufacturing Company Ltd. $TSM — MarketBeat
Sun, 26 Jul 2026 Matrix Private Capital Group LLC Acquires New Position in Blackstone Inc. $BX — MarketBeat
Sun, 26 Jul 2026 Matrix Private Capital Group LLC Acquires New Position in Merck & Co., Inc. $MRK — MarketBeat
Fees and Compensation — Form ADV Part 2A (7/10/2026) [Brochure]
Item 5. Fees and Compensation
Matrix provides investment advisory services to its Clients pursuant to separate investment
management and/or limited partner agreements (the “Agreements”). The Agreements for each of its
Clients, including the SPVs, along with the Governing Fund Documents, set forth in detail the fee
structure relevant to each Client.

Matrix receives compensation from fees based on a percentage of assets under management
(“Management Fee”) and carried interest (“Carried Interest”). Clients may be subject to certain
other fees or expenses related to transactions (i.e. account maintenance fees, custodial fees,
transaction fees and fees charged by other investment managers as described below). Clients and
investors should review all fees charged by Matrix and others to fully understand the total amount
of fees to be paid by Clients, including the SPVs.

Private Special Purpose Co-Investment Vehicles

Matrix receives no management fee from Banff or Veritas. Matrix will receive a management fee
equal to 0.25% per annum of the total amount of capital invested by Denali into the Co-Invest
Vehicle. Matrix will receive a management fee equal to 0.50% per annum of the total amount of
capital invested by Novva into the Co-Invest Vehicle. The management fee shall be payable
quarterly in arrears. Matrix will receive Carried Interest from Limited Partners of Banff equal to
10% of their cumulative distributions in excess of their capital contributed. Matrix will receive
Carried Interest from Limited Partners of Veritas equal to up to 12.5% of their cumulative
distributions in excess of their capital contributed over a certain hurdle amount. Matrix will receive
Carried Interest from Limited Partners of Denali equal to 15% of their cumulative distributions in

Form ADV Part 2A: Firm Brochure | Matrix Private Capital Group LLC                       July 10, 2026

excess of their capital contributed. Carried Interest from Limited Partners of Novva equal to 15%
of their cumulative distributions in excess of their capital contributed [over a certain hurdle amount].

The information provided in this Brochure regarding fees and expenses is not intended to be
complete or final and is qualified in its entirety by the governing documents for each SPV. Investors
should read and review the governing documents to fully understand the types of fees and expenses
that are paid by each SPV.

Wealth Management/Managed Accounts

For Client relationships established prior to May 1, 2019:
Account fees are generally paid quarterly in advance and deducted from the client account each
quarter. Should the account be opened on any day other than the first day of the quarter, the fee
will be pro-rated based on the remaining days left in the quarter. Thereafter, the fee will be based
on the account value on the last business day of the previous calendar quarter. Should a client wish
to terminate an account on a date other than the last day of a calendar quarter, a pro-rated refund of
unearned fees will be made based on the days left in the calendar quarter.

For Client relationships established May 1, 2019 and after:
Matrix will generally deduct advisory fees from the account(s) on a quarterly basis by applying one-
fourth (1/4th) of the advisory fees rate after the last day of March, June, September, and December
of each year. The advisory fees will be calculated based upon the average daily balance of the assets
held during the billable (preceding) calendar quarter, taking into account all calendar days in which
assets of the client were managed by Adviser.

Clients must provide notice of termination in accordance with the terms of the investment advisory
agreement.

Discretionary Wealth Management

For discretionary wealth management services, Matrix’s Clients typically pay an annual fee of up
to 1.5% on assets under management. The fees will be determined based upon a number of factors
including but not limited to, the scope and complexity of work, the size of client assets, and the
amount of resources involved in providing the services. To the extent that the Adviser recommends
that a client invests a portion of its assets in an SPV, the Adviser will not charge this annual fee in
respect of such assets. Therefore, the client would only pay the fees in respect of any assets invested
in an SPV. This is generally a performance-based allocation for the SPVs, as described above. A
conflict of interest exists as Matrix’s compensation may be higher when Client assets are invested
in the SPVs as a result of the performance-based allocation. In addition, wealth advisers receive a
portion of the performance-based allocation of SPVs through ownership of the general partner. The
amount of the wealth advisers’ clients that invest in the SPV is a factor in determining ownership
of the general partner. This creates a conflict of interest as wealth advisers have an incentive to
recommend that Client assets are invested in the SPVs. Matrix only recommends that a Client
invest its assets in the SPVs when Matrix believes the investment is in the Client’s best interest.

Non-discretionary Advisory Services

Form ADV Part 2A: Firm Brochure | Matrix Private Capital Group LLC                       July 10, 2026

For non-discretionary assets under advisement, the Adviser’s Clients will typically pay no more
than an annual fee equal to 1.5% based on the value of assets under advisement. Additionally,
Matrix may provide non-discretionary advisory services for a fixed fee which will be negotiated on
a client-by-client basis.

Other Fees and Expenses

Clients may also be subject to other fees paid to third parties including account maintenance fees,
custodial fees and transaction charges in addition to the fees outlined above. In addition to Matrix’s
fees, Clients may also incur the management fees and any other expenses of any mutual funds or
...
Account Minimums and Types of Clients — Form ADV Part 2A (7/10/2026) [Brochure]
Item 7. Types of Clients
Matrix serves as investment manager to SPVs and Managed Accounts.

Matrix primarily provides customized wealth management and advisory services to high net worth
individuals and families and their associated trusts, estates, and other legal entities. The Adviser
does not impose a minimum account size to become an advisory client; however, investment
managers recommended by Matrix may require a minimum amount of investable assets to open
and maintain an account.
Sector Form 13F Holdings Value ($B)
AURA Biosciences Inc 0.0
 
 
 
 
 
 
 
 
 
 
Holdings by Sector ($B)
151296302011201620212027
Type Form D Funds Date Sold AUM
Other Matrix Novva LLC [2026-03-27] 12.3 M 15.1 M
Offered $15,150,000 · Filed 2025-04-21 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining $2,865,000 · Duration One year or less · Net Assets $5,000,001 - $25,000,000
Other Matrix Denali LP [2024-03-26] 10.4 M 6.1 M
Offered $10,400,000 · Filed 2023-09-28 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Duration One year or less · Net Assets $5,000,001 - $25,000,000
Other Matrix Veritas LP [2020-03-30] 4.9 M 0.1 M
Filed 2020-03-10 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $50,000 · Remaining Indefinite · Duration One year or less · Net Assets $1 - $5,000,000
Other Matrix Banff LP [2019-03-28] 5.4 M 10.5 M
Offered $5,365,000 · Filed 2018-10-10 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $30,000 · Duration One year or less · Net Assets $5,000,001 - $25,000,000
HF Matrix Highline LP 2018-01-26 10.4 M
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 84 67.7
(b) Individuals (high net worth individuals) 124 382.9
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 4 31.9
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 10 78.6
(n) Other 0 0.0
Total 827 561.0
By Discretionary
Discretionary 827 561.0
Non-Discretionary 0 0.0
Total 827 561.0
By Non-United States Persons
Non-United States Persons 0.9
United States Persons 560.0
Total 827 561.0
Form D Directors Role # Filings # Firms 2011 - 2026
Matthew Rubin Director 12 2
Richard Fuld Director, Executive Officer 5 2
Richard Kravitz Director, Executive Officer 4 2
Robert Wohl Executive Officer 2 2
Scott Weissman Director 2 2
Marc Scheuer Director, Executive Officer 4 1
Charlie Wemyss Executive Officer 1 1
Lance Bryan Director 1 1
Charles Wemyss Director 1 1
Seth Scher Executive Officer 1 1
View All
EDGAR Form CIK 2011 - 2026
13F-HR [0001410830]
3 [0001410830]
4 [0001410830]
SC 13D [0001410830]
SC 13G [0001410830]
13F-HR [0001906866]
Form 13D/13G Filer Form 13D/13G Subject Filed
Matrix Capital Management Company LP Maze Therapeutics Inc [2025-05-14]
Matrix Capital Management Company LP Zentalis Pharmaceuticals Inc [2022-06-03]
Matrix Capital Management Company LP Forgerock Inc [2022-02-14]
Matrix Capital Management Company LP Perimeter Solutions Sa [2022-02-14]
Matrix Capital Management Company LP AURA Biosciences Inc [2021-11-04]
Matrix Capital Management Company LP Bigcommerce Holdings Inc [2021-02-16]
Matrix Capital Management Company LP Zentalis Pharmaceuticals Inc [2021-02-16]
Matrix Capital Management Company LP Altair Engineering Inc [2020-02-14]
Matrix Capital Management Company LP Adaptive Biotechnologies Corp [2020-02-14]
Matrix Capital Management Company LP Cargurus Inc [2019-02-14]
Matrix Capital Management Company LP Tableau Software Inc [2019-02-14]
Matrix Capital Management Company LP Trillium Therapeutics Inc [2017-12-08]
Matrix Capital Management Company LP Adaptimmune Therapeutics PLC [2017-09-11]
Matrix Capital Management Company LP Pandora Media Inc [2017-02-10]
Matrix Capital Management Company LP New Relic Inc [2016-02-16]
Matrix Capital Management Company LLC Tableau Software Inc [2014-08-15]
Matrix Capital Management Company LLC Carters Inc [2012-04-20]
Firm Profile (Form ADV)
ServesInstitutional, Retail
Fund TypesHedge Fund
Form 3/4/5 Subject 2011 - 2026
Matrix Capital Management Company LP
Aura Biosciences Inc
GOEL David E
Zentalis Pharmaceuticals Inc
Adaptive Biotechnologies Corp
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Zentalis Pharmaceuticals Inc ZNTL
Common Stock, par value $0.001 per share
2025-12-15 Sell 7,500,000 $1.33 9,975,000
Aura Biosciences Inc AURA
Common Stock, par value $0.00001 per share (Common Stock)
2023-11-09 Buy 1,560,000 $9.00 14,040,000
Zentalis Pharmaceuticals Inc ZNTL
Common Stock, par value $0.001 per share
2023-06-20 Buy 4,760,000 $22.66 107,861,600
Aura Biosciences Inc AURA
"Common Stock, par value $0.00001 per share (""Common Stock"")"
2022-12-05 Buy 1,250,000 $12.00 15,000,000
Aura Biosciences Inc AURA
Common Stock
2021-11-02 Buy 1,785,000 $14.00 24,990,000
Aura Biosciences Inc AURA
Series E Convertible Preferred Stock · derivative
2021-11-02 Conversion 2,327,870 $0.00
Aura Biosciences Inc AURA
"Common Stock, par value $0.00001 per share (""Common Stock"")"
2021-11-02 Conversion 2,327,870
Adaptive Biotechnologies Corp ADPT
Common Stock
2021-03-10 Sell 30,268 $42.38 1,282,758
Adaptive Biotechnologies Corp ADPT
Common Stock
2021-03-10 Sell 25,732 $41.47 1,067,106
Adaptive Biotechnologies Corp ADPT
Common Stock
2021-03-09 Sell 34,302 $41.16 1,411,870
Adaptive Biotechnologies Corp ADPT
Common Stock
2021-03-09 Sell 215,698 $40.42 8,718,513
Adaptive Biotechnologies Corp ADPT
Common Stock
2021-03-08 Sell 71,194 $41.21 2,933,905
Adaptive Biotechnologies Corp ADPT
Common Stock
2021-03-08 Sell 234,295 $38.22 8,954,755
Adaptive Biotechnologies Corp ADPT
Common Stock
2021-03-08 Sell 75,000 $39.22 2,941,500
Adaptive Biotechnologies Corp ADPT
Common Stock
2021-03-08 Sell 33,600 $39.97 1,342,992
Adaptive Biotechnologies Corp ADPT
Common Stock
2021-03-08 Sell 85,911 $41.62 3,575,616
Adaptive Biotechnologies Corp ADPT
Common Stock
2020-07-20 Sell 2,000,000 $40.00 80,000,000
Adaptive Biotechnologies Corp ADPT
Common Stock
2020-01-24 Conversion 2,217,101 $26.50 58,753,176
Adaptive Biotechnologies Corp ADPT
Common Stock
2019-07-01 Conversion 84,359
Adaptive Biotechnologies Corp ADPT
Series E-1 Convertible Preferred Stock · derivative
2019-07-01 Conversion 5,893,716 $0.00
showing 20 of 26 most recent transactions
Comparable Firms State AUM
Hyperion Capital Advisors LP
NY 581.3 M
Able Wealth Management LLC
NJ 579.5 M
Valueworks LLC
NY 577.3 M
Capital Markets IQ LLC
571.4 M
Loom Capital Management LLC
NY 570.8 M
Bulldog Investors LLP
NJ 561.0 M
Empirical Asset Management LLC
MA 560.0 M
Snider Retirement Strategies Inc
WA 549.7 M
Cable Car Capital LP
CA 548.3 M
Aristides Capital LLC
KY 541.4 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com